Guided Therapeutics (GTHP) 10-K2009 FY Annual report

Filed: 23 Mar 10, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: ac, alloca, anner, anti, arrive, ASC, ASU, authoritative, awa, Basel, clarify, Codification, comp, condi, de, Dec, deducted, deliverable, East, ed, eleven, ember, Esq, etection, etermination, etition, ew, extinguished, extinguishment, financia, formally, fractional, goverance, iginal, impo, inducement, inducing, IRS, ithdrawal, jury, Licen, lim, LOC, ly, meant, Mike, Millennium, modifica, Mongin, mortized, moveme, multiyear, Nationa, NIH, nongovernmental, Noteholder, onica, osition, ot, outflow, Pacific, Peachtree, petitive, preceeding, prod, quired, quoted, ramp, regulat, reorganizing, residual, role, roughly, rs, rsion, Seattle, sed, selec, simplify, simplifying, sing, Spectrascience, stabilizing, straight, Subtopic, subtracted, Switzerland, team, ted, ting, tion, Topic, treasury, ultimat, uncertianty, velopment, write

Removed: accounted, admitted, APB, approximate, Arthur, Avalon, breast, buyer, called, CEO, choose, consultant, contractual, County, defaulting, dilute, diluted, dilutive, ending, escrow, evaluated, exist, explanatory, forma, goodwill, hub, ICU, impairment, imposed, indirect, infringement, infusion, injury, insertion, ISF, location, lowered, movement, mutual, notice, operational, paragraph, Parkway, Pavlicek, payroll, prevalent, pro, profit, range, reimburse, relationship, relied, researchand, resolved, revised, Ridge, SAB, schedule, selecting, suit, terminate, ultimately, unqualified, utilize, Walter, withdrawal, wrongdoing

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

GTHP similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32

SECTION 1350 CERTIFICATION

In connection with the Annual Report of Guided Therapeutics, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mark L. Faupel, President, Chief Executive Officer and Acting Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 23, 2010

/s/ MARK L. FAUPEL

Name: Mark L. Faupel

Title: President, Chief Executive Officer and

Acting Chief Financial Officer